Genetic tests could help predict some irregular heartbeats and prevent the sudden cardiac death that strikes more than 300,000 Americans a year, a pair of studies suggests.

The research announced Monday by device maker Medtronic found an association between a single gene and 50 percent higher odds of heart rhythms called ventricular tachyarrhythmias, which can turn fatal.

Although the link does not prove a genetic abnormality causes the danger, researchers said, doctors eventually may use the discovery to help identify candidates for implanted defibrillators that avert cardiac arrest.

“This is a step in the right direction — no question about it,” said Samir Saba, chief of cardiac electrophysiology at Downtown-based UPMC.

Advertise with us

Dr. Saba said published guidelines focus on heart muscle strength when doctors consider the implants for patients without past cardiac problems. But he said the approach by itself lacks sophistication, leaving a lot of at-risk people without the device and others with implants they won’t need.

“We’re not doing too well with the sensitivity,” Dr. Saba said. Fatality rates run about 90 percent among patients who suffer sudden, nontraumatic cardiac arrest outside a hospital, according to the Sudden Cardiac Arrest Foundation.

Dublin-based Medtronic, the largest medical device company in the world, helped pay for the research presented at the European Society of Cardiology Congress in London. The work involves two studies — one based out of St. Marien-Hospital Mulheim in Germany that involved 1,145 patients in Europe, the other an ongoing effort led through the Cedars-Sinai Heart Institute in Los Angeles.

Medtronic generally does not say how much it spends on individual studies, spokeswoman Kathleen Janasz said. Its products include defibrillator implants.

Earlier studies uncovered genetic links to other atypical heart activity, said Srinivas Murali, the Cardiovascular Institute director at the North Side-based Allegheny Health Network.

Advertise with us

“If you identify the people at risk, maybe you can do something about preventing it,” Dr. Murali said.

Sudden cardiac death, or an unexpected fatality caused by heart failure, is the largest cause of natural death in the United States, accounting for about 325,000 fatalities a year and about half of heart disease deaths, according to the Cleveland Clinic.

Doctors in the future will likely use genetic data in concert with heart imaging, electrocardiograms and other evaluations to tailor individual therapies, Dr. Saba said.

“Eventually, the way I see all these genetic markers is fine-tuning or improving the ability” to treat, he said.

Adam Smeltz: asmeltz@post-gazette.com, 412-263-2625 or on Twitter @asmeltz.